• SENSEX 76,492.36
    467.85 (+0.62%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)

IPO

Explore our secure online trading, IPO bidding, mutual fund investments, and depository services, all designed to provide seamless transactions, expert insights, and real-time market access for smart investing

Veeda Clinical Research Ltd

Veeda Clinical Research Ltd

    Registered Office : Shivalik Plaza - A 2nd Floor,Ambawadi,Ahmedabad Gujarat 380015 Phone : 91-79-6777 3000
    Fax :

    Email : investor.relation@veedalifesciences.com

    Website : www.veedalifesciences.com

Initial public offering of up to [*] equity shares of face value of Rs. 2/- each ("Equity Shares") of Veeda Clinical Research Limited ("the Company" or the "Company" or the "Issuer") for cash at a price of Rs. [*] per equity share (including a Share Premium of Rs. [*] per Equity Share) ("Offer Price") aggregating up to Rs. [*] crores ("Offer") comprising a fresh issue of [*] equity shares of face value of Rs. 2/- each aggregating up to Rs. 185.00 crores ("Fresh Issue") and an offer for sale of up to 13,008,128 equity shares of face value of Rs. 2/- each ("Offered Shares") aggregating up to Rs. [*] crores, comprising an offer for sale of up to 3,493,895 equity shares of face value of Rs. 2/- each aggregating up to Rs. [*] crores by Basil Private Limited ("Promoter Selling Shareholder") and up to 9,514,233 equity shares of face value of Rs. 2/- each aggregating up to Rs. [*] crores by the other selling shareholders (as Defined Hereinafter and Together with the Promoter Selling Shareholder, the "Selling Shareholders" and such offer by the selling shareholders, the "Offer for Sale"). The offer shall constitute [*] % of the post-offer paid-up equity share capital of the company. The company, in consultation with the brlms, may consider an issue of specified securities as may be permitted under the applicable law aggregating up to Rs. 37.00 crores prior to filing of the pre-ipo placement, if undertaken, will be at a price to be decided by its company. The face value of the equity shares is Rs. 2/- each. The offer price is [*] times the face value of the equity shares of Rs. 2/- each. The price band and the minimum bid lot will be decided by the company.

Issue

Opens On

Closes On

01-Jan-1970

01-Jan-1970

Money Payable On

Application

Allotment

0.00

0.00

Minimum Application for shares in Nos : 0.0 Further Multiples of : 0.0

₹Cr

Lead Managers to the Issue

Project Cost (₹.Cr)

Project Financed through Current Offer (₹.Cr)

Post Issue Equity Share Capital (₹.Cr)

Issue Price (₹.Cr)

0.00

0.00

0.00

0.00

Axis Capital Ltd

CLSA India Pvt ltd

IIFL Capital Services Ltd

SBI Capital Markets Ltd

Projects
  • Capital expenditure towards procurement of equipment and machinery for the company
  • Investment in the compay material subsidiary, Bioneeds India Pvt ltd for capital expenditure towards procurement of equipment and machinery
  • Investment in the company material subsidiary, Bioneeds India Pvt Ltd for repayment/pre-payment, in part or full of certain borrowings of Bioneeds India Pvt Ltd
  • Funding organic growth of the com., the co., its material subsidiary, Bioneeds (I) Pvt Ltd & Health Data Specialists (Holdings) Ltd through mak., & promotional activities, updation of tech., & adoption of modern digital solutions in its worrkflo
  • General corporate purposes
Promoted By
  • Basil Pvt Ltd
Listing At
  • BSE
  • NSE
Registrar to the Issue
  • MUFG Intime India Pvt Ltd